BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2015

Jan 28, 2015

SEC Form 4/A — Form 4/A

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2014-05-12

Reporting Person: FUCHS HENRY J (EVP, Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-05-12	Common Stock	F	3001	$59.30	Disposed	64849	Direct
2014-05-13	Common Stock	S	1434	$58.2274	Disposed	63415	Direct

Footnotes

F1: The price in colum 4 is weighted average price. the price actually receved for ranged from $57.30 to $59.00. The reporting person will provide to the isuer, any security holder of the issuer, or the SEC staff, upon rquest, information regarding the number of shares sold at each price within the range.